ABC294640

YELIVA®

Overview

ABC294640 is a new drug being investigated as a treatment for myeloma. It is administered orally and has anti-cancer and anti-inflammatory activities.

SparkCures ID 254
Brand Name Yeliva®
Generic Name ABC294640

Clinical Trials

All Clinical Trials

View all active clinical trials around the US.

Early Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received one to two prior lines of therapy.

Late Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.

Smoldering Myeloma
Monoclonal Gammopathy of Undetermined Significance (MGUS)

Resources

There are no resources, links or videos to display for this treatment.